Who owns Elevation Oncology Inc?
- Ticker: ELEV
- CUSIP Number: 28623u101
Tip: Access positions for across all investors
Analyze quarterly positions in Elevation Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Elevation Oncology stock
Who bought or sold Elevation Oncology Inc this quarter?
There are no current stakeholders of Elevation Oncology.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Elevation Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 1.4M | $523k |
| Citadel Advisors | Jun 2025 | 405k | $149k |
| Two Sigma Investments | Jun 2025 | 254k | $93k |
| Two Sigma Advisers | Jun 2025 | 107k | $39k |
| AQR Capital Management | Jun 2025 | 52k | $19k |
| FMR | Jun 2025 | 49k | $18k |
| Balyasny Asset Management | Jun 2025 | 12k | $4.5k |
| Advisor Group Holdings | Sep 2025 | 2.0k | $720.000000 |